Recruiting

Photodynamic Therapy

Sponsor:

Main Line Health

Code:

NCT01842555

Conditions

Lung Cancer

Esophageal

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Registry

Study Details

Brief summary:

The data elements for the PDT Registry project include virtually all the elements in the standard hospital-based cancer registry record, although in some cases at a finer level of detail. All data points should be found in the participant's medical record. The principal difference between the PDT Registry data set and that collected by the registries is the inclusion of more information specific to PDT.

Conditions

Lung Cancer

Esophageal

Study ID

NCT01842555

Start date

Nov, 2012

Status verified date

Aug, 2018

Completion date

Dec 30, 2024

Anticipated

Primary completion date

Nov, 2024

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • 18 years of age or older, male or female, diagnosed with cancer and is undergoing or has undergone Photodynamic Therapy (PDT).
  • Patients must have undergone PDT with Photofrin® at a participating institution.
  • Patients scheduled to undergo PDT with Photofrin®
  • Cancer patients receiving some or all primary care (e.g.,cancer-directed surgery, systemic therapy, radiation therapy, palliative care)in the participating institution.
  • Cancer patients with a history of any type of cancer who have been no evidence of disease(for five years but without a history of distant metastases or evidence of relapse if they meet the previous criteria).

Exclusion Criteria:

  • Cancer patients who present to the participating institution with a diagnosis of a simultaneous second primary.
  • Cancer patients receiving all primary cancer care (e.g., cancer-directed surgery, chemotherapy, targeted therapy, radiation therapy, palliative care) outside of participating institution.
  • Patients treated with photosensitizers other than Photofrin®

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Arms

PDT registry patients

Any newly diagnosed lung or esophageal cancer that is being being treated with PDT at a participating institution.

Interventions

Registry

Registry

Primary outcome measure

  • A Photodynamic Therapy (PDT) research repository and de-identified registry [ Time Frame: Up to 3 years ]

Central Contacts and Locations

Central contacts

Patsy Skabla, PA

SkablaP@mlhs.org

Locations

Main Line Health, Lankenau Medical Center

Recruiting

Wynnewood, Pennsylvania, United States, 19096

Contacts

Patsy Skabla, PA

SkablaP@mlhs.org

Principal Investigator:

Patrick Ross, MD, PhD

More Information

Sponsor

Main Line Health

Last update posted

Aug 24, 2018

Last verified

Aug, 2018

Keywords

  • PDT
  • Photodynamic therapy

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Main Line Health on 2018-08-24.